Genenta Science S.p.A. - American Depositary Shares (GNTA)
1.8000
+0.1200 (7.14%)
NASDAQ · Last Trade: Nov 24th, 11:13 AM EST
Detailed Quote
Previous Close
1.680
Open
1.840
Bid
1.790
Ask
1.820
Day's Range
1.750 - 1.840
52 Week Range
1.350 - 10.00
Volume
68,462
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,933,149
Chart
About Genenta Science S.p.A. - American Depositary Shares (GNTA)
Genenta Science S.p.A. is a biotechnology company focused on developing innovative gene therapies for oncology. The company specializes in harnessing the power of its proprietary, engineered cell-based therapies to combat various forms of cancer. By using genetic engineering techniques, Genenta aims to create treatments that can enable the immune system to recognize and fight tumors effectively. Their research and development efforts are centered on creating safe and effective therapeutic options for patients facing significant health challenges due to cancer, with the goal of transforming the landscape of cancer treatment through cutting-edge science and technology. Read More
The company said that 25 patients have been treated with Temferon as of November 21, and 44% of glioblastoma multiforme patients have reached 18-month survival.
Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, announced continued momentum for its flagship brand FOCUSfactor® following several key milestones and retail expansions across North America, UK, UAE, Turkey and Latin America.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that it has entered into a securities purchase agreement with institutional investors to purchase 4,285,715 American Depositary Shares ("ADSs") at an offering price of $3.50 per ADS, for gross proceeds of approximately $15.0 million, before deducting placement agent fees and other estimated offering expenses. All of the securities in the offering were sold by Genenta, and no warrants or other derivative securities were issued in connection with this offering.
Myseum Inc. (NASDAQ: MYSE), a privacy-first social media and technology innovator, is capturing investor and media attention this week as CEO Darin Myman takes to the airwaves, sharing his vision for how Myseum’s technology could dramatically disrupt the social media landscape as we know it. The market has taken notice. MYSE shares have been active this week , closing Wednesday, October 22, 2025, at $2.68 and surging to an intraday high of $3.07 on Thursday on strong volume — reflecting growing investor enthusiasm as the company’s technology gains wider recognition.
